Back to search
FDAFDA · Food and drugs·Recall number D-1074-2019

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Published April 10, 2019 · Recall initiated: March 29, 2019

Summary

FDA records drug Class II recall D-1074-2019, published April 10, 2019 and initiated March 29, 2019. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 12,960 bottles; Lot: Lot #: PA217060A, Exp 05/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Nationwide in the USA.
Lot
Lot #: PA217060A, Exp 05/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90. recalled?

Yes. FDA published recall D-1074-2019 on April 10, 2019. Reported hazard: Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter